🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the combination of Pegylated Alfa ...
Status
Terminated
Location
Baylor College of Medicine - Methodist Hospital
Start Date
2007-05
Trial ID
NCT00522249
Treatments Being Tested
Test the safety, immune response and efficacy of GVAX pancreas vaccine (wit...
Status
Completed
Location
Scottsdale Healthcare Research Institute
Start Date
2014-02-05
Trial ID
NCT02004262
Treatments Being Tested
The goal of this clinical research study is to find the highest tolerable d...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2009-04
Trial ID
NCT00895362
The main purpose of this first study combining an investigational dual mTOR...
Status
Completed
Location
Cedars Sinai Medical Center, Inflammatory Bowel Disease Center
Start Date
2012-05-01
Trial ID
NCT01545947
Treatments Being Tested
This is a Phase Ib/II, open-label, single institution dose-escalation, safe...
Status
Terminated
Location
University of Texas Health Science Center at San Antonio
Start Date
2024-12-27
Trial ID
NCT06516887
Treatments Being Tested
The goal of this clinical research study is to find the highest tolerable d...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2007-06
Trial ID
NCT00495872
Treatments Being Tested
Define the maximum tolerated dose and dose limiting side-effects of temsiro...
Status
Completed
Location
Washington University School of Medicine
Start Date
2009-05
Trial ID
NCT00770263
Treatments Being Tested
The purpose of the study is to evaluate the efficacy of the combination of ...
Status
Completed
Location
Spanish Cooperative Group for Digestive Tumour Therapy
Start Date
2011-02
Trial ID
NCT01303029
Treatments Being Tested
This open-label, non-randomized, multicenter, Phase 1/2 study will evaluate...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2013-06-20
Trial ID
NCT01801111
Pancreatic cancer is an aggressive, largely chemo-resistant disease with a ...
Status
Completed
Location
The Royal Marsden Foundation Hospital NHS Trust
Start Date
2005-11
Trial ID
NCT00260364